Sridhar Kosaraju - 11 Jun 2021 Form 4 Insider Report for 10x Genomics, Inc. (TXG)

Role: Director
Signature: /s/ Eric S. Whitaker, as Attorney-in-Fact
Issuer symbol: TXG
Transactions as of: 11 Jun 2021
Net transactions value: $0
Form type: 4
Filing time: 15 Jun 2021, 17:49:53 UTC
Previous filing: 26 May 2021
Next filing: 25 Jun 2021
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	TXG	Class A Common Stock	Award	$0	+625	+22%	$0.000000	3,458	11 Jun 2021	Direct	F1
holding	TXG	Class A Common Stock						13,500	11 Jun 2021	See Footnote	F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	TXG	Stock Option (right to buy)	Award	$0	+1,563		$0.000000	1,563	11 Jun 2021	Class A Common Stock	1,563	$193.51	Direct	F3

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	These securities are restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of Class A Common Stock. One-fourth of the RSUs, granted pursuant to the Issuer's 2019 Omnibus Incentive Plan, shall vest on August 21, 2021 and on each three-month anniversary thereafter, subject to the Reporting Person continuing as a service provider through each such date.
F2	These shares are held by the Kosaraju Family Trust dated June 21, 2014, of which the Reporting Person is trustee.
F3	This option, granted pursuant to the Issuer's 2019 Omnibus Incentive Plan, vests as to one-twelfth of the shares on July 11, 2021 and each month thereafter, subject to the Reporting Person continuing as a service provider through each such date.